Alzheimer's Disease clinical trials in Illinois
32 active Alzheimer's Disease trials with a site in Illinois. Describe your situation to see which ones you may be eligible for.
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
- OTC Hearing Aid and MCI
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Mindfulness Walking Intervention to Enhance Resilience (iWalk)
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Late Onset Alzheimer's Disease
- RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
- Implementation of AIP Services for Older Adults With AD
- Alzheimer's Disease Neuroimaging Initiative 4
- The Diabetes Prevention Program Outcomes Study AD/ADRD Project
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
- Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
- SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.